kneat.com, inc. (TSE:KSI - Free Report) - Investment analysts at Cormark issued their Q2 2025 EPS estimates for kneat.com in a research note issued to investors on Tuesday, July 22nd. Cormark analyst G. Fairweather expects that the company will post earnings per share of ($0.01) for the quarter. The consensus estimate for kneat.com's current full-year earnings is ($0.12) per share.
kneat.com Stock Down 1.8%
Shares of TSE KSI traded down C$0.10 during midday trading on Thursday, hitting C$5.60. The company's stock had a trading volume of 45,802 shares, compared to its average volume of 86,208. The business's fifty day simple moving average is C$6.18 and its two-hundred day simple moving average is C$6.30. The company has a debt-to-equity ratio of 85.50, a current ratio of 1.43 and a quick ratio of 1.50. kneat.com has a 1 year low of C$4.30 and a 1 year high of C$7.25. The firm has a market capitalization of C$523.61 million, a price-to-earnings ratio of -60.49, a price-to-earnings-growth ratio of 597.67 and a beta of 1.08.
kneat.com Company Profile
(
Get Free Report)
kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.
Featured Articles
Before you consider kneat.com, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.
While kneat.com currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
